Which hedge funds own CGON? CG ONCOLOGY INC, Q2 2026 13F holders
35 tracked hedge funds disclosed a position in CGON (CG ONCOLOGY INC) in their Q2 2026 13F filings, worth $1.7bn in total. The largest holder by portfolio weight is Decheng Capital LLC at 61.9% of its book. 7 opened a new position this quarter: Ground Swell Capital, LLC, Prelude Capital Management, LLC, Alyeska Investment Group, L.P., DeepCurrents Investment Group LLC. 16 exited: Elmind Capital, LP, Braidwell LP, Silverarc Capital Management, LLC.
- 35
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 7
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 16
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $7.1m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $191m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $1.7bn
- Combined value Sum of the holders' reported positions in the security.
- 2.8%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Elmind Capital, LP | 5.6% | $19.7m |
| Braidwell LP | 2.2% | $66.7m |
| Silverarc Capital Management, LLC | 1.3% | $11.3m |
| Arrowpoint Investment Partners (Singapore) Pte. Ltd. | 0.3% | $228k |
| Farallon Capital Management, L.L.C. | 0.3% | $45.6m |
| Bayforest Capital Ltd | 0.2% | $210k |
| Nantahala Capital Management, LLC | 0.2% | $3.3m |
| SummitTX Capital, L.P. | 0.09% | $2.7m |
| Point72 Asset Management, L.P. | 0.05% | $27.0m |
| PDT Partners, LLC | 0.04% | $757k |
| Fox Run Management, L.L.C. | 0.04% | $211k |
| RWC Asset Management LLP | 0.01% | $223k |
| Citadel Advisors LLC | 0.01% | $11.7m |
| Brevan Howard Capital Management LP | 0.01% | $785k |
| Hudson Bay Capital Management LP | 0.0% | $506k |
| Magnetar Financial LLC | 0.0% | $208k |
Ownership over time
Who discovered CGON first? Beta
| Decheng Capital LLC high conviction | Q2 2024 | +36.5 pts |
| Avidity Partners Management LP high conviction | Q3 2025 | +15.5 pts |
| Braidwell LP | Q2 2024 | +2.4 pts |
| Soleus Capital Management, L.P. | Q1 2024 | 0.0 pts |
| Cormorant Asset Management, LP | Q1 2024 | 0.0 pts |
| Perceptive Advisors LLC | Q1 2024 | −0.3 pts |
| Frazier Life Sciences Management, L.P. | Q1 2024 | −0.5 pts |
| Ally Bridge Group (NY) LLC high conviction | Q1 2024 | −3.5 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.